Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Sell
47
EKG Quote, Financials, Valuation and Earnings
Last price:
$17.43
Seasonality move
:
4.44%
Day range:
$17.40 - $17.40
52-week range:
$15.11 - $18.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
144
Avg. volume:
294
1-year change:
7.85%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
|
-- | -- | -- | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
|
$17.33 | -- | -- | -- | $0.00 | 0% | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
$24.33 | -- | -- | -- | $0.24 | 0.98% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$167.18 | -- | -- | -- | $1.17 | 0.7% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
|
-- | 1.528 | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | 1.890 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 1.249 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
|
-- | -- | -- | -- | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
First Trust Nasdaq Lux Digi Health Solutions ETF vs. Competitors
-
Which has Higher Returns EKG or BBC?
Virtus LifeSci Biotech Clinical Trials ETF has a net margin of -- compared to First Trust Nasdaq Lux Digi Health Solutions ETF's net margin of --. First Trust Nasdaq Lux Digi Health Solutions ETF's return on equity of -- beat Virtus LifeSci Biotech Clinical Trials ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EKGFirst Trust Nasdaq Lux Digi Health Solutions ETF-- -- -- BBCVirtus LifeSci Biotech Clinical Trials ETF-- -- -- -
What do Analysts Say About EKG or BBC?
First Trust Nasdaq Lux Digi Health Solutions ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Clinical Trials ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Nasdaq Lux Digi Health Solutions ETF has higher upside potential than Virtus LifeSci Biotech Clinical Trials ETF, analysts believe First Trust Nasdaq Lux Digi Health Solutions ETF is more attractive than Virtus LifeSci Biotech Clinical Trials ETF.
Company Buy Ratings Hold Ratings Sell Ratings EKGFirst Trust Nasdaq Lux Digi Health Solutions ETF0 0 0 BBCVirtus LifeSci Biotech Clinical Trials ETF0 0 0 -
Is EKG or BBC More Risky?
First Trust Nasdaq Lux Digi Health Solutions ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Clinical Trials ETF has a beta of 1.043, suggesting its more volatile than the S&P 500 by 4.293%.
-
Which is a Better Dividend Stock EKG or BBC?
First Trust Nasdaq Lux Digi Health Solutions ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Virtus LifeSci Biotech Clinical Trials ETF offers a yield of 0.98% to investors and pays a quarterly dividend of $0.24 per share. First Trust Nasdaq Lux Digi Health Solutions ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Clinical Trials ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EKG or BBC?
First Trust Nasdaq Lux Digi Health Solutions ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Clinical Trials ETF quarterly revenues of --. First Trust Nasdaq Lux Digi Health Solutions ETF's net income of -- is lower than Virtus LifeSci Biotech Clinical Trials ETF's net income of --. Notably, First Trust Nasdaq Lux Digi Health Solutions ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Clinical Trials ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Nasdaq Lux Digi Health Solutions ETF is -- versus -- for Virtus LifeSci Biotech Clinical Trials ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EKGFirst Trust Nasdaq Lux Digi Health Solutions ETF-- -- -- -- BBCVirtus LifeSci Biotech Clinical Trials ETF-- -- -- --
-
Which has Higher Returns EKG or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to First Trust Nasdaq Lux Digi Health Solutions ETF's net margin of --. First Trust Nasdaq Lux Digi Health Solutions ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EKGFirst Trust Nasdaq Lux Digi Health Solutions ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About EKG or FBT?
First Trust Nasdaq Lux Digi Health Solutions ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Nasdaq Lux Digi Health Solutions ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe First Trust Nasdaq Lux Digi Health Solutions ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings EKGFirst Trust Nasdaq Lux Digi Health Solutions ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is EKG or FBT More Risky?
First Trust Nasdaq Lux Digi Health Solutions ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.671, suggesting its less volatile than the S&P 500 by 32.903%.
-
Which is a Better Dividend Stock EKG or FBT?
First Trust Nasdaq Lux Digi Health Solutions ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.7% to investors and pays a quarterly dividend of $1.17 per share. First Trust Nasdaq Lux Digi Health Solutions ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EKG or FBT?
First Trust Nasdaq Lux Digi Health Solutions ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. First Trust Nasdaq Lux Digi Health Solutions ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, First Trust Nasdaq Lux Digi Health Solutions ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Nasdaq Lux Digi Health Solutions ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EKGFirst Trust Nasdaq Lux Digi Health Solutions ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
